Comments on: Cancer Vaccine Therapies: Failures and Future Opportunities

By: Ipilimumab Approval Highlights Active Immunotherapy Renaissance | Life Science Digest

Sun, 27 Mar 2011 12:47:23 +0000

[...] highlighted in our firm’s April 2010 report titled “Cancer Vaccine Therapies: Failures and Future Opportunities,” there are a number of additional catalysts that could ignite further interest in the field of [...]

By: Five Key Factors Weighing on Dendreon | Life Science Digest

Five Key Factors Weighing on Dendreon | Life Science Digest — Thu, 01 Jul 2010 19:24:16 +0000

[...] early April 2010, we published a 150-page industry report titled “Cancer Vaccine Therapies: Failures and Future Opportunities,” which included an overview of the cancer immunotherapy market, interviews with several key [...]

By: Cancer Immunotherapy to Take Center Stage at ASCO | Life Science Digest

Cancer Immunotherapy to Take Center Stage at ASCO | Life Science Digest — Thu, 03 Jun 2010 11:56:25 +0000

[...] for the major industry participants. An executive summary of the report can be found by clicking here. Some of the key messages from the report include the [...]